NHS National Framework for Generics Housekeeping

Buyer: NHS England

Deadline

Not available — this notice may describe a possible future opportunity.

Region

Not specified

Value

£21,562,716

Type

Award,contract

SME fit

—

Duration

—

Description

NHS National Framework for Generics Housekeeping Offer reference number: CM/PHG/25/5733 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/25/5733/01 Oral products CESW/LSNE/NWLN 01/02/2026 to 31/05/2027 (16 months) CM/PHG/25/5733/02 Hospital only products DCE/DSW 01/02/2026 to 30/09/2027 (20 months) DLS/DNE: 01/02/2026 to 31/01/2027 (12 months) DLN/DNW 01/02/2026 to 31/01/2027 (12 months)

Awarded to

Alissa Healthcare Research Limited £17,843,324 Brown & Burk UK Ltd £17,843,324 Chiesi Limited £17,843,324 Crescent Pharma Ltd £17,843,324 Day Lewis Medical Ltd £17,843,324 Drugsrus Ltd £21,562,716 Infectopharm Ltd £17,843,324 Luye Pharma Ltd £17,843,324 Relonchem Ltd £17,843,324 Rosemont Pharmaceuticals Limited £17,843,324 Thornton and Ross Ltd £17,843,324 Mercury Pharmaceuticals Limited £21,562,716 Milpharm Ltd £21,562,716 Pfizer Ltd £21,562,716 Teva UK Limited £21,562,716 ACCORD-UK LTD £21,562,716 Kent Pharma Ltd £21,562,716 Martindale Pharma £21,562,716 Amarox Limited £21,562,716 Baxter Healthcare Ltd £21,562,716 Biocon £21,562,716 CIPLA (EU) LIMITED £21,562,716 DR REDDY'S LABORATORIES (UK) LIMITED £21,562,716 Grindeks Kalceks UK Ltd £21,562,716 hameln pharma ltd £21,562,716 Hikma Pharmaceuticals £21,562,716 JCSH Pharma Ltd £21,562,716 Novartis Pharmaceuticals UK Ltd £21,562,716 Novumgen Limited £21,562,716 Seacross Pharmaceuticals Ltd £21,562,716 Sun Pharma UK Ltd £21,562,716 Tillomed Laboratories Ltd £21,562,716 Viatris UK Healthcare Limited £21,562,716 Wockhardt UK Limited £21,562,716 Zentiva Pharma UK Ltd £21,562,716 Medreich PLC £17,843,324 Morningside Pharmaceuticals £17,843,324 RPH Pharmaceuticals AB £21,562,716 Zydus Pharmaceuticals UK Ltd £21,562,716

Quick actions

View original notice

Key details

CPV category: —
Procurement method: Open procedure
Published: 11 Nov 2025 11:06
VCSE suitable: —

Reference

OCID: ocds-h6vhtk-058823
Notice ID: C382260
In our database since: 18 Aug 2026